These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 17720884)
21. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. Piris MA; Medeiros LJ; Chang KC Pathology; 2020 Jan; 52(1):154-165. PubMed ID: 31699300 [TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma. Al-Salam S; Awwad A; Alashari M Int J Clin Exp Pathol; 2014; 7(11):7508-17. PubMed ID: 25550786 [TBL] [Abstract][Full Text] [Related]
23. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315 [TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma. Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699 [TBL] [Abstract][Full Text] [Related]
25. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis. Mueller NE; Lennette ET; Dupnik K; Birmann BM Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472 [TBL] [Abstract][Full Text] [Related]
27. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669 [TBL] [Abstract][Full Text] [Related]
28. [Hodgkin's disease and Epstein-Barr virus]. Depil S; Moralès O; Auriault C Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. Sivachandran N; Sarkari F; Frappier L PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293 [TBL] [Abstract][Full Text] [Related]
30. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. Kapatai G; Murray P J Clin Pathol; 2007 Dec; 60(12):1342-9. PubMed ID: 18042690 [TBL] [Abstract][Full Text] [Related]
31. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. Niedobitek G; Päzolt D; Teichmann M; Devergne O J Pathol; 2002 Nov; 198(3):310-6. PubMed ID: 12375263 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176 [TBL] [Abstract][Full Text] [Related]
33. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Baumforth KR; Flavell JR; Reynolds GM; Davies G; Pettit TR; Wei W; Morgan S; Stankovic T; Kishi Y; Arai H; Nowakova M; Pratt G; Aoki J; Wakelam MJ; Young LS; Murray PG Blood; 2005 Sep; 106(6):2138-46. PubMed ID: 15933052 [TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults. Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887 [TBL] [Abstract][Full Text] [Related]
35. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216 [TBL] [Abstract][Full Text] [Related]
36. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH; Peh SC; Poppema S Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421 [TBL] [Abstract][Full Text] [Related]
37. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers. Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548 [TBL] [Abstract][Full Text] [Related]